Chemical hair relaxer lawsuits alleging uterine and ovarian cancer are consolidated in the Northern District of Illinois. Funding bridges the long wait.
The chemical hair relaxer MDL in the Northern District of Illinois consolidates thousands of cases alleging that long-term use of relaxers caused uterine cancer, ovarian cancer, and other reproductive cancers.
Bellwether trials and settlement negotiations are still developing. Most claimants face long timelines and substantial cancer treatment expenses.
AARC provides pre-settlement funding on qualifying hair relaxer cases with no credit check. Funding is non-recourse and repaid only at settlement.
Underwriting focuses on documented long-term relaxer use, diagnosis of a covered cancer, and attorney representation.
Cases in the MDL with strong documentation support advances appropriate to the expected recovery.
Call (800) 297-3834 or apply online to see what your hair relaxer case qualifies for.
